Corcept Therapeutics Incorporated logo CORT - Corcept Therapeutics Incorporated

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 14
HOLD 10
SELL 2
STRONG
SELL
0
| PRICE TARGET: $83.00 DETAILS
HIGH: $135.00
LOW: $30.00
MEDIAN: $91.50
CONSENSUS: $83.00
UPSIDE: 3.87%
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001
Revenue
Revenue 761.4 675.0 482.4 401.9 366.0 353.9 306.5 251.2 159.2 81.3 50.3 26.6 10.4 3.3 0 0 0.0 0.2 0.5 0.3 0 0 0 0 0
Cost of Revenue 13.0 10.9 6.5 5.4 5.3 5.6 5.5 5.2 3.6 2.1 1.4 0.9 0.1 0.1 0 0 0 0 0 0 0 0 0 0 0
Gross Profit 748.4 664.2 475.9 396.5 360.7 348.3 301.0 246.0 155.6 79.3 48.9 25.7 10.2 3.2 0 0 0.0 0.2 0.5 0.3 0 0 0 0 0
Operating Expenses
R&D Expenses 254.9 246.9 184.4 131.0 113.9 114.8 89.0 75.2 40.4 23.8 15.4 18.4 20.5 14.1 21.0 18.9 14.4 14.2 7.9 20.8 17.1 11.6 8.1 13.3 5.4
SG&A Expenses 448.7 280.3 184.3 152.8 122.4 105.3 100.4 81.3 62.4 45.2 36.9 34.9 31.2 25.4 11.3 8.5 5.9 5.7 4.9 5.0 4.1 4.5 1.9 5.5 2.6
Other Expenses 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Operating Expenses 703.6 527.2 368.6 283.8 236.2 220.1 189.4 156.5 102.8 69.1 52.4 53.3 51.7 39.5 32.3 27.4 20.3 19.9 12.7 25.9 21.2 16.0 10.0 18.8 8.0
Operating Income
Operating Income 44.8 137.0 107.3 112.6 124.5 128.2 111.6 89.5 52.9 10.2 (3.4) (27.6) (41.5) (36.3) (32.3) (27.4) (20.2) (19.7) (12.2) (25.6) (21.2) (16.0) (10.0) (18.8) (8.0)
Interest Expense 0 0 0 0 0 0 0 0 0.0 2.0 3.0 3.8 4.5 1.8 0.0 1.5 0.1 0.9 0 0 0 0 0 0 0
Interest Income 21.7 24.5 17.3 3.6 0.5 3.4 5.1 2.7 0 0 0 0 0 0 0 0 0 0 0.7 0 0 0 0 0 0
Profitability
EBITDA 68.4 162.8 125.6 117.5 128.0 130.4 113.8 89.7 53.0 10.3 (3.3) (27.5) (41.4) (36.2) (32.4) (26.0) (20.2) (19.7) (12.2) (25.6) (20.1) (15.5) (10.0) (18.8) (8.0)
EBIT 66.5 161.5 124.6 116.2 125.0 128.2 111.6 89.5 52.9 10.1 (3.4) (27.6) (41.5) (36.3) (32.4) (26.0) (20.2) (19.7) (12.2) (25.6) (20.1) (15.5) (10.0) 0 0
Income Before Tax 66.5 161.5 124.6 116.2 125.0 131.6 116.7 92.2 52.8 8.1 (6.4) (31.4) (46.0) (38.0) (32.4) (26.0) (20.2) (20.1) (11.6) (24.9) (20.1) (15,534.5) 0 0 0
Income Tax Expense (33.2) 20.3 18.4 14.8 12.5 25.6 22.5 16.7 (76.3) 0 0 0 0 0 0.0 0 (0.1) 0 0 0 0 (0.5) (0.2) 18.5 7.5
Net Income 99.7 139.7 106.1 101.4 112.5 106.0 94.2 75.4 129.1 8.1 (6.4) (31.4) (46.0) (38.0) (32.4) (26.0) (20.2) (20.1) (11.6) (24.9) (20.1) (15.5) (9.8) (18.5) (7.5)
Per Share Data
EPS (Basic) 0.95 1.35 1.02 0.95 0.97 0.92 0.82 0.60 1.14 0.07 -0.06 -0.31 -0.46 -0.41 -0.39 -0.38 -0.38 -0.43 -0.34 -1.09 -0.89 -0.84 -1.13 -2.75 -1.39
EPS (Diluted) 0.82 1.23 0.94 0.87 0.89 0.85 0.77 0.60 1.04 0.07 -0.06 -0.31 -0.46 -0.41 -0.39 -0.38 -0.38 -0.43 -0.34 -1.09 -0.89 -0.84 -1.13 -2.75 -1.39
Shares Outstanding 103.9 103.2 103.6 106.8 115.7 115.4 114.3 125.7 113.5 110.6 106.8 101.0 99.8 93.0 83.3 68.3 52.4 46.7 34.3 22.8 22.6 18.4 8.7 6.7 5.4
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001
Current Assets
Cash & Cash Equivalents 120.5 127.7 135.6 66.3 77.6 76.2 31.3 206.8 104.0 51.5 40.4 24.2 54.9 93.0 39.6 24.6 23.9 14.7 11.4 8.9 3.8 5.9 10.1 0 0
Short-Term Investments 251.7 255.7 232.7 365.3 145.9 364.5 244.7 0 0 0 0 0 0 0 0 0 0 3.6 5.9 0.6 25.3 31.5 1.5 0 0
Net Receivables 59.8 58.1 56.8 46.9 29.0 26.2 19.9 17.6 28.2 9.9 6.2 3.3 1.4 0.6 0 0 0 0 0 0 0 0 0 0 0
Inventory 12.9 12.4 7.7 6.1 5.0 4.9 5.4 16.2 8.4 2.3 1.7 1.2 1.1 0.9 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 12.2 8.3 25.9 14.6 8.9 6.7 6.0 7.7 2.7 2.0 0.6 1.4 0.9 0.6 0.1 0.4 0.6 1.3 0.3 0.3 0.4 0.8 0 0 0
Total Current Assets 485.5 471.6 458.6 499.3 266.5 478.5 307.4 240.6 140.6 65.7 49.0 30.2 58.3 95.1 39.8 25.0 24.4 19.6 17.7 9.8 29.5 38.2 11.7 0 0
Non-Current Assets
Property, Plant & Equipment 6.5 8.0 0.3 1.8 1.5 4.2 4.5 0.7 0.5 0.2 0.1 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0 0.0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long-Term Investments 160.3 219.8 57.2 4.9 112.3 36.2 39.4 0 15.3 0 0 0 0 0 0 0 0 0 0 0 0.5 9,485.5 0 0 0
Other Non-Current Assets 16.2 10.2 14.8 16.0 16.0 21.2 15.4 7.8 3.2 2.9 2.9 4.2 4.6 4.0 0.0 0.1 0.1 0.2 0.1 0.1 0.1 (9,476.0) 0.0 0 0
Total Non-Current Assets 351.2 369.0 162.9 84.2 157.3 93.2 105.0 71.1 79.9 3.1 3.0 4.4 4.8 4.1 0.1 0.1 0.1 0.2 0.1 0.1 0.7 9.5 0.0 0 0
Total Assets 836.7 840.6 621.5 583.4 423.8 571.7 412.3 311.7 220.5 68.8 51.9 34.6 63.1 99.2 39.8 25.1 24.5 19.8 17.7 9.9 30.2 47.8 11.8 21.8 24.3
Current Liabilities
Account Payables 40.4 15.4 17.4 12.0 6.9 10.6 7.5 8.3 8.6 2.3 1.3 1.9 2.4 3.8 3.6 0.8 1.3 1.3 1.1 0.9 0.5 0.6 0.3 0 0
Short-Term Debt 0 0.8 0.2 1.1 0.5 2.0 1.6 0 0 14.7 15.0 9.4 5.7 2.6 0 0 0.0 0.0 0.0 0.0 0.0 0 0 0 0
Deferred Revenue 35.7 0 0 0 0 0 0 0 0 0 0.2 0.0 0.0 0.0 0 0 0 0 0 0 0 0 0 0 0
Other Current Liabilities 44.3 82.6 59.7 43.8 26.3 24.7 16.9 17.9 12.4 5.7 3.3 1.6 4.1 1.5 1.2 1.2 0.9 1.3 1.2 2.4 2.8 0.9 0 0 0
Total Current Liabilities 166.1 140.8 104.5 72.5 47.5 47.5 38.8 35.8 29.6 27.4 20.9 13.6 12.7 8.4 5.0 3.9 2.4 2.9 3.0 3.5 3.5 1.8 1.0 0 0
Non-Current Liabilities
Long-Term Debt 5.0 0 0 0 0 0 0 0 0 0 0 24.5 29.3 29.0 0 0 0 0 0 0 0 0 0.5 0 0
Deferred Tax Liabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 17.7 14.1 10.3 9.1 0.4 0.4 0.4 0.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Non-Current Liabilities 22.8 20.2 10.3 9.1 0.4 0.9 2.3 0.2 0 0 12.6 24.5 29.3 29.0 0 0 0 0.0 0.0 0.0 0.0 0 0.5 0 0
Total Liabilities 188.8 161.0 114.8 81.6 48.0 48.4 41.1 35.8 29.6 27.4 33.4 38.0 42.1 37.4 5.0 3.9 2.4 2.9 3.0 3.5 3.6 1.8 1.5 43.7 1.9
Stockholders' Equity
Common Stock 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0 0
Retained Earnings 643.4 543.7 402.5 296.4 195.0 82.5 (23.6) (117.7) (193.1) (322.3) (330.4) (324) (292.6) (246.6) (208.6) (176.2) (150.2) (130.1) (110.0) (98.4) (73.6) (53.5) (37.9) 0 0
Accumulated Other Comprehensive Income 2.3 (0.2) 0.6 (0.9) (0.2) 0.4 0.3 (0.1) (0.1) (0.5) (0.4) (0.3) (0.1) (0.1) (0.1) (0.0) 0 (0.0) (0.1) (0.4) (0.9) (2.0) (0.0) 0 0
Total Stockholders' Equity 647.8 679.6 506.7 501.8 375.8 523.3 371.2 275.9 191.0 41.4 18.5 (3.4) 21.0 61.8 34.8 21.2 22.1 16.9 14.7 6.4 26.6 45.9 10.2 (21.9) 22.4
Total Liabilities & Equity 836.7 840.6 621.5 583.4 423.8 571.7 412.3 311.7 220.5 68.8 51.9 34.6 63.1 99.2 39.8 25.1 24.5 19.8 17.7 9.9 30.2 47.8 11.8 21.8 24.3
Debt Metrics
Total Debt 6.1 6.9 0.2 1.1 0.5 2.6 3.5 0 0 14.7 15.0 9.4 5.7 2.6 0 0 0.0 0.0 0.0 0.0 0.1 0 0.5 0 0
Net Debt (114.4) (120.7) (135.4) (65.2) (77.1) (73.6) (27.8) (206.8) (104.0) (36.9) (25.5) (14.8) (49.1) (90.4) (39.6) (24.6) (23.9) (14.7) (11.4) (8.9) (3.8) (5.9) (9.5) 0 0
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003
Operating Activities
Net Income 98.2 141.2 106.1 101.4 112.5 106.0 94.2 75.4 129.1 8.1 (6.4) (31.4) (46.0) (38.0) (32.4) (26.0) (20.2) (20.1) (11.6) (24.9) (20.1) (15.5) (9.8)
Depreciation & Amortization 1.9 1.3 2.4 3.4 3.1 2.2 2.2 0.2 0.1 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.6 0.0
Stock-Based Compensation 84.5 61.4 48.9 42.4 42.9 33.5 29.3 23.7 13.4 7.1 6.0 5.2 5.2 5.3 3.4 2.1 1.8 1.6 1.1 0 0.7 1,609.4 0
Change in Working Capital (27.6) 45.3 8.2 5.5 (0.1) (5.4) (4.7) 3.9 (5.7) 1.2 0.5 (5.0) (0.8) (5.0) 1.5 1.6 0.4 (1.2) (0.5) 0.1 2.1 0.1 (0.5)
Other Non-Cash Items (15.0) (10.9) (9.1) 1.4 5.1 1.5 (1.7) (1.7) 0.8 1.9 2.9 3.7 4.4 1.7 0 0 0.0 1.3 1.1 1.6 0.1 0.1 0.3
Operating Cash Flow 142.0 198.1 127.0 120.3 167.9 152.0 136.1 115.7 60.9 18.4 3.1 (27.4) (37.1) (36.0) (27.4) (22.3) (18.0) (18.4) (11.0) (23.2) (17.2) (13.7) (10.0)
Investing Activities
Capital Expenditure (0.2) (2.2) (0.1) (0.4) (0.5) (1.2) (1.1) (0.3) (0.4) (0.2) (0.0) (0.2) (0.1) (0.2) (0.0) 0 (0.0) (0.0) 0 (1.3) (25.9) (103.9) 0
Acquisitions 0 0 0 0 (136.6) 118.0 116.7 0 0 0 0 0 0 0 0 0 0 0 0 0 25.9 0 0
Purchases of Investments (319.6) (588.3) (328.7) (355.1) (312.8) (420.1) (299.0) (233.1) (73.0) 0 0 0 0 0 0 0 (3.6) (3.6) (6.4) 0 (25.9) (103,898.3) (11.7)
Sales/Maturities of Investments 389.6 412.9 419.8 241.2 449.4 302.1 182.3 142.7 0 0 0 0 0 0 0 0 3.6 5.9 1 26.7 41.0 64.4 13.3
Other Investing Activities 0 0 0 0 136.6 (118.0) (116.7) (90.5) (73.0) 0 0 0 0 0 0 0 3.6 0 0 0 (0.1) 103,898.3 0
Investing Cash Flow 69.8 (177.6) 90.9 (114.3) 136.1 (119.3) (117.8) (90.8) (73.5) (0.2) (0.0) (0.2) (0.1) (0.2) (0.0) 0 3.6 2.3 (5.4) 25.4 15.1 (39.5) 1.6
Financing Activities
Net Debt Issuance 0 0 0 0 0 0 0 0 (15.1) (14.8) (9.2) (4.9) 0 29.9 0 (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) 0 0
Stock Repurchased (245.9) (15.7) (145.4) 0 (296.0) (9.9) (31.0) (23.7) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 25.5 (22.3) (3.3) (17.3) (6.6) 22.2 2.3 9.3 7.2 7.7 22.3 1.8 (1.0) 59.7 0 0 0 0 0.0 0.0 0.0 0.1 0.0
Financing Cash Flow (220.4) (28.3) (148.7) (17.3) (302.6) 12.2 (28.6) (14.3) (8.0) (7.1) 13.1 (3.1) (1.0) 89.6 42.5 23.0 23.5 19.3 18.9 3.0 0.0 49.1 0.0
Cash Position
Net Change in Cash (7.2) (7.9) 69.2 (11.3) 1.4 44.9 (10.4) 10.6 (20.5) 11.1 16.2 (30.6) (38.2) 53.4 15.1 0.7 9.2 3.3 2.5 5.1 (2.1) (4.1) (8.3)
Cash at Beginning 127.7 135.6 66.3 77.6 76.2 31.3 41.6 31.1 51.5 40.4 24.2 54.9 93.0 39.6 24.6 23.9 14.7 11.4 8.9 3.8 5.9 10.1 18.4
Cash at End 120.5 127.7 135.6 66.3 77.6 76.2 31.3 41.6 31.1 51.5 40.4 24.2 54.9 93.0 39.6 24.6 23.9 14.7 11.4 8.9 3.8 5.9 10.1
Free Cash Flow 141.8 195.9 126.9 119.9 167.4 150.7 135.0 115.4 60.5 18.2 3.1 (27.6) (37.2) (36.2) (27.4) (22.3) (18.0) (18.4) (11.0) (24.6) (43.1) (117.6) (10.0)
Key Metrics 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001
Income Statement
Revenue 761.4 675.0 482.4 401.9 366.0 353.9 306.5 251.2 159.2 81.3 50.3 26.6 10.4 3.3 0 0 0.0 0.2 0.5 0.3 0 0 0 0 0
Gross Profit 748.4 664.2 475.9 396.5 360.7 348.3 301.0 246.0 155.6 79.3 48.9 25.7 10.2 3.2 0 0 0.0 0.2 0.5 0.3 0 0 0 0 0
Operating Income 44.8 137.0 107.3 112.6 124.5 128.2 111.6 89.5 52.9 10.2 (3.4) (27.6) (41.5) (36.3) (32.3) (27.4) (20.2) (19.7) (12.2) (25.6) (21.2) (16.0) (10.0) (18.8) (8.0)
Net Income 99.7 139.7 106.1 101.4 112.5 106.0 94.2 75.4 129.1 8.1 (6.4) (31.4) (46.0) (38.0) (32.4) (26.0) (20.2) (20.1) (11.6) (24.9) (20.1) (15.5) (9.8) (18.5) (7.5)
EPS (Diluted) 0.82 1.23 0.94 0.87 0.89 0.85 0.77 0.60 1.04 0.07 -0.06 -0.31 -0.46 -0.41 -0.39 -0.38 -0.38 -0.43 -0.34 -1.09 -0.89 -0.84 -1.13 -2.75 -1.39
Balance Sheet
Cash & Equivalents 120.5 127.7 135.6 66.3 77.6 76.2 31.3 206.8 104.0 51.5 40.4 24.2 54.9 93.0 39.6 24.6 23.9 14.7 11.4 8.9 3.8 5.9 10.1 0 0
Total Assets 836.7 840.6 621.5 583.4 423.8 571.7 412.3 311.7 220.5 68.8 51.9 34.6 63.1 99.2 39.8 25.1 24.5 19.8 17.7 9.9 30.2 47.8 11.8 21.8 24.3
Total Debt 6.1 6.9 0.2 1.1 0.5 2.6 3.5 0 0 14.7 15.0 9.4 5.7 2.6 0 0 0.0 0.0 0.0 0.0 0.1 0 0.5 0 0
Stockholders' Equity 647.8 679.6 506.7 501.8 375.8 523.3 371.2 275.9 191.0 41.4 18.5 (3.4) 21.0 61.8 34.8 21.2 22.1 16.9 14.7 6.4 26.6 45.9 10.2 (21.9) 22.4
Cash Flow
Operating Cash Flow 142.0 198.1 127.0 120.3 167.9 152.0 136.1 115.7 60.9 18.4 3.1 (27.4) (37.1) (36.0) (27.4) (22.3) (18.0) (18.4) (11.0) (23.2) (17.2) (13.7) (10.0)
Capital Expenditure (0.2) (2.2) (0.1) (0.4) (0.5) (1.2) (1.1) (0.3) (0.4) (0.2) (0.0) (0.2) (0.1) (0.2) (0.0) 0 (0.0) (0.0) 0 (1.3) (25.9) (103.9) 0
Free Cash Flow 141.8 195.9 126.9 119.9 167.4 150.7 135.0 115.4 60.5 18.2 3.1 (27.6) (37.2) (36.2) (27.4) (22.3) (18.0) (18.4) (11.0) (24.6) (43.1) (117.6) (10.0)